152 related articles for article (PubMed ID: 26714600)
1. [Relationship between parameters of dynamic contrast-enhanced MRI and clinical stage of nasopharyngeal carcinoma].
Yu X; Li F; Hu Y; Lu Q; Wang H
Zhonghua Zhong Liu Za Zhi; 2015 Aug; 37(8):597-602. PubMed ID: 26714600
[TBL] [Abstract][Full Text] [Related]
2. Dynamic contrast-enhanced MRI of nasopharyngeal carcinoma: a preliminary study of the correlations between quantitative parameters and clinical stage.
Zheng D; Chen Y; Chen Y; Xu L; Chen W; Yao Y; Du Z; Deng X; Chan Q
J Magn Reson Imaging; 2014 Apr; 39(4):940-8. PubMed ID: 24108569
[TBL] [Abstract][Full Text] [Related]
3. Value of dynamic contrast-enhanced magnetic resonance imaging for determining the plasma Epstein-Barr virus status and staging of nasopharyngeal carcinoma.
Sriyook A; Lertbutsayanukul C; Jittapiromsak N
Clin Imaging; 2021 Apr; 72():1-7. PubMed ID: 33190027
[TBL] [Abstract][Full Text] [Related]
4. The therapeutic utility of combining dynamic contrast-enhanced magnetic resonance imaging with arterial spin labeling in the staging of nasopharyngeal carcinoma.
Li H; Gong G; Wang L; Su Y; Lu J; Yin Y
BMC Med Imaging; 2023 May; 23(1):61. PubMed ID: 37138205
[TBL] [Abstract][Full Text] [Related]
5. Quantitative Analysis of DCE-MRI and RESOLVE-DWI for Differentiating Nasopharyngeal Carcinoma from Nasopharyngeal Lymphoid Hyperplasia.
Yu JY; Zhang D; Huang XL; Ma J; Yang C; Li XJ; Xiong H; Zhou B; Liao RK; Tang ZY
J Med Syst; 2020 Feb; 44(4):75. PubMed ID: 32103352
[TBL] [Abstract][Full Text] [Related]
6. DCE-MRI assessment of the effect of Epstein-Barr virus-encoded latent membrane protein-1 targeted DNAzyme on tumor vasculature in patients with nasopharyngeal carcinomas.
Liao WH; Yang LF; Liu XY; Zhou GF; Jiang WZ; Hou BL; Sun LQ; Cao Y; Wang XY
BMC Cancer; 2014 Nov; 14():835. PubMed ID: 25407966
[TBL] [Abstract][Full Text] [Related]
7. Investigating the correlation of arterial spin labeling and dynamic contrast enhanced perfusion in primary tumor of nasopharyngeal carcinoma.
Lin M; Yu X; Luo D; Ouyang H; Xie L; Wu B; Zhou C
Eur J Radiol; 2018 Nov; 108():222-229. PubMed ID: 30396660
[TBL] [Abstract][Full Text] [Related]
8. Dynamic contrast-enhanced MRI of nasopharyngeal carcinoma: correlation of quantitative dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) parameters with hypoxia-inducible factor 1α expression and tumor grade/stage.
Liu L; Hu L; Zeng Q; Peng D; Chen Z; Huang C; Liu Z; Wen Q; Zou F; Yan L
Ann Palliat Med; 2021 Feb; 10(2):2238-2253. PubMed ID: 33725777
[TBL] [Abstract][Full Text] [Related]
9. Combination of diffusion-weighted imaging and arterial spin labeling at 3.0 T for the clinical staging of nasopharyngeal carcinoma.
Xiao B; Wang P; Zhao Y; Liu Y; Ye Z
Clin Imaging; 2020 Oct; 66():127-132. PubMed ID: 32480267
[TBL] [Abstract][Full Text] [Related]
10. Dynamic contrast-enhanced magnetic resonance imaging for characterising nasopharyngeal carcinoma: comparison of semiquantitative and quantitative parameters and correlation with tumour stage.
Huang B; Wong CS; Whitcher B; Kwong DL; Lai V; Chan Q; Khong PL
Eur Radiol; 2013 Jun; 23(6):1495-502. PubMed ID: 23377545
[TBL] [Abstract][Full Text] [Related]
11. Dynamic Contrast-Enhanced Magnetic Resonance Imaging of Regional Nodal Metastasis in Nasopharyngeal Carcinoma: Correlation with Nodal Staging.
Huang B; Kwong DL; Lai V; Chan Q; Whitcher B; Khong PL
Contrast Media Mol Imaging; 2017; 2017():4519653. PubMed ID: 29097922
[TBL] [Abstract][Full Text] [Related]
12. Nasopharyngeal carcinoma perfusion MRI: Comparison of arterial spin labeling and dynamic contrast-enhanced MRI.
Xiao B; Wang P; Zhao Y; Liu Y; Ye Z
Medicine (Baltimore); 2020 May; 99(22):e20503. PubMed ID: 32481470
[TBL] [Abstract][Full Text] [Related]
13. Dynamic contrast-enhanced MRI predicts PTEN protein expression which can function as a prognostic measure of progression-free survival in NPC patients.
Wu G; Huang W; Xu J; Li W; Wu Y; Yang Q; Liu K; Zhu M; Balasubramanian PS; Li M
J Cancer Res Clin Oncol; 2022 Jul; 148(7):1771-1780. PubMed ID: 34398299
[TBL] [Abstract][Full Text] [Related]
14. Quantitative dynamic contrast-enhanced and diffusion-weighted MRI for differentiation between nasopharyngeal carcinoma and lymphoma at the primary site.
Yu XP; Hou J; Li FP; Xiang W; Lu Q; Hu Y; Wang H
Dentomaxillofac Radiol; 2016; 45(3):20150317. PubMed ID: 26846711
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of the Pretreatment Primary Lesion Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Nasopharyngeal Carcinoma.
Qin Y; Yu X; Hou J; Hu Y; Li F; Wen L; Lu Q; Liu S
Acad Radiol; 2019 Nov; 26(11):1473-1482. PubMed ID: 30772137
[TBL] [Abstract][Full Text] [Related]
16. Combining dynamic contrast enhanced magnetic resonance imaging and microvessel density to assess the angiogenesis after PEI in a rabbit VX2 liver tumor model.
Chen J; Qian T; Zhang H; Wei C; Meng F; Yin H
Magn Reson Imaging; 2016 Feb; 34(2):177-82. PubMed ID: 26518059
[TBL] [Abstract][Full Text] [Related]
17. Intravoxel incoherent motion MR imaging in nasopharyngeal carcinoma: comparison and correlation with dynamic contrast enhanced MR imaging.
Lai V; Lee VHF; Lam KO; Huang B; Chan Q; Khong PL
Oncotarget; 2017 Sep; 8(40):68472-68482. PubMed ID: 28978131
[TBL] [Abstract][Full Text] [Related]
18. Early response to chemoradiotherapy for nasopharyngeal carcinoma treatment: Value of dynamic contrast-enhanced 3.0 T MRI.
Zheng D; Chen Y; Liu X; Chen Y; Xu L; Ren W; Chen W; Chan Q
J Magn Reson Imaging; 2015 Jun; 41(6):1528-40. PubMed ID: 25136770
[TBL] [Abstract][Full Text] [Related]
19. Value of Diffusion-Weighted Imaging and Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Prediction of Treatment Outcomes in Nasopharyngeal Carcinoma.
Paprad T; Lertbutsayanukul C; Jittapiromsak N
J Comput Assist Tomogr; 2022 Jul-Aug 01; 46(4):664-672. PubMed ID: 35483078
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance of dynamic contrast-enhanced magnetic resonance imaging parameters and serum tumor markers in rectal carcinoma prognosis.
Mu RQ; Lv JW; Ma CY; Ma XH; Xing D; Ma HS
World J Gastrointest Oncol; 2024 May; 16(5):1796-1807. PubMed ID: 38764818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
